Genre
Journal ArticleDate
2010Author
Masciullo, VAmadio, G
Lo Russo, D
Raimondo, I
Giordano, A
Scambia, G
Subject
1112 Oncology and CarcinogenesisClinical
Clinical Medicine and Science
Uterine Cancer
Contraception/Reproduction
Cancer
Clinical Research
Cancer
Permanent link to this record
http://hdl.handle.net/20.500.12613/5556
Metadata
Show full item recordDOI
10.1155/2010/638165Abstract
<jats:p>Endometrial cancer (EC) remains the most common malignancy of the female genital tract. The median age at diagnosis is the sixth decade, with abnormal uterine bleeding at the presentation in 90% of the patients. Surgical treatment, including complete hysterectomy, removal of remaining adnexal structures, and an appropriate surgical staging, represents the milestone of curative therapy for patients with EC. Adjuvant therapy is necessary in patients at high risk of recurrence. Conservative treatment approaches should be used in selected cases for women with a desire of fertility preservation. This review summarizes the management of EC and discusses current controversies regarding the role of lymphadenectomy and radiotherapy in patients with intermediate-risk tumors confined to the uterus.</jats:p>Citation to related work
Hindawi LimitedHas part
Obstetrics and Gynecology InternationalADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduae974a485f413a2113503eed53cd6c53
http://dx.doi.org/10.34944/dspace/5538